Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast Cancer Exercise Intervention Study (BREXINT)

NCT05957068 is registered in ClinicalTrials.gov with National Cancer Centre, Singapore as lead sponsor.

NCT NCT05957068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05957068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast Cancer Exercise Intervention Study (BREXINT)
Lead sponsor
National Cancer Centre, Singapore
Phase
Not applicable
Overall status
Recruiting
Start date
July 1, 2023
Completion date
May 31, 2033
Enrollment
2,156 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

early-stage breast cancer, locally advanced breast cancer